Real-world experience with inclisiran: 12 month data from the Hammersmith Hospital Lipid Clinic

被引：0
|
作者：
Jackson, E. K. [1 ]
Padam, P. [1 ]
Barton, L. [1 ]
Wilson, S. [1 ]
David, A. [1 ,2 ]
Walji, S. [1 ]
de Lorenzo, F. [1 ]
Ray, K. K. [1 ,3 ]
Jones, B. [1 ,4 ]
Cegla, J. [1 ,4 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Dept Cardiol, Lipids & Cardiovasc Risk Serv, London, England
[2] Imperial Coll London, Dept Life Sci, Ctr Bioinformat, London, England
[3] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
[4] Imperial Coll London, Div Diabet Endocrinol & Metab, London, England
来源：
ATHEROSCLEROSIS PLUS | 2023年 / 54卷
关键词：
D O I：
10.1016/j.athplu.2023.07.022
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] PCSK9 INHIBITION: "REAL WORLD" EXPERIENCE FROM THE HAMMERSMITH HOSPITAL LIPID CLINIC, LONDON
    Cegla, Jaimini
    Walji, Shahenaz
    Jones, Ben
    Scott, James
    [J]. ATHEROSCLEROSIS, 2017, 263 : E244 - E245
  • [2] Lipid lowering with inclisiran: a real-world single-centre experience
    Padam, Pritpal
    Barton, Lucy
    Wilson, Stewart
    David, Alessia
    Walji, Shahenaz
    de Lorenzo, Ferruccio
    Ray, Kausik K.
    Jones, Ben
    Cegla, Jaimini
    [J]. OPEN HEART, 2022, 9 (02):
  • [3] Real-World 12-Month Weight Loss Outcomes of Tirzepatide-The Mayo Clinic Experience
    Fansa, Sima
    Tama, Elif
    Safwan, Nancy
    Ghusn, Wissam
    Anazco, Diego
    Acosta, Andres
    Hurtado, Maria D.
    [J]. DIABETES, 2024, 73
  • [4] Real-World fremanezumab experience from headache clinic in Moscow
    Azimova, J.
    Skorobogatykh, K.
    Uzhakhov, A.
    Vashchenko, N.
    Kukushkin, M.
    Korobkova, D.
    Kornienko, S.
    Mamkhegov, E.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [5] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [6] Patch Testing in an Allergy Clinic: Real-world Experience
    Rosenberg-Bezalel, Shira
    Elbirt, Daniel
    Mahlab-Guri, Keren
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (10): : 649 - 653
  • [7] LIPOPROTEIN (A): A CONCEALED PRECURSOR OF INCREASED CARDIOVASCULAR RISK? A REAL-WORLD REGIONAL LIPID CLINIC EXPERIENCE
    Anastasiou, G.
    Sakka, E.
    Blathra, E.
    Kalivi, A.
    Elisaf, M.
    Liamis, G.
    Liberopoulos, E.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E141 - E141
  • [8] Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience
    Anastasiou, Georgia
    Sakka, Eftihia
    Blathra, Efi
    Kalivi, Anna
    Elisaf, Moses
    Liamis, George
    Liberopoulos, Evangelos
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (04) : 397 - 404
  • [9] Evolocumab real-world data: five-year experience of an Italian hospital
    Bellato, N.
    Campanardi, M. C.
    Calzavara, E.
    Nobili, S.
    De Vivo, G.
    Cambareri, M.
    Veneziano, C.
    Atzeni, F.
    Andena, M.
    Ciceri, E.
    Richelmi, P.
    Vimercati, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 791 - 791
  • [10] Hereditary spastic paraparesis: The real-world experience from a Neurogenetics outpatient clinic
    Cunha, Ines A.
    Ribeiro, Joana A.
    Santos, Maria Cj
    [J]. EUROPEAN JOURNAL OF MEDICAL GENETICS, 2022, 65 (03)
12345